Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vasodilation | 2 | 2020 | 258 | 0.89 | Why? |
| Heart-Assist Devices | 5 | 2020 | 812 | 0.81 | Why? |
| Prosthesis Implantation | 2 | 2019 | 261 | 0.75 | Why? |
| Triiodobenzoic Acids | 1 | 2018 | 12 | 0.74 | Why? |
| Vasoplegia | 1 | 2018 | 27 | 0.73 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.64 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.63 | Why? |
| Lipocalin-2 | 1 | 2017 | 156 | 0.62 | Why? |
| Central Venous Catheters | 1 | 2017 | 188 | 0.59 | Why? |
| Heart Failure | 8 | 2021 | 6638 | 0.54 | Why? |
| Catheterization, Peripheral | 1 | 2017 | 249 | 0.53 | Why? |
| Heart Defects, Congenital | 5 | 2020 | 933 | 0.48 | Why? |
| Endothelium, Vascular | 2 | 2020 | 1751 | 0.47 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.45 | Why? |
| Coronary Artery Bypass | 1 | 2018 | 629 | 0.44 | Why? |
| Acute Kidney Injury | 3 | 2019 | 5762 | 0.38 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.38 | Why? |
| Ventricular Function, Left | 1 | 2018 | 1555 | 0.38 | Why? |
| Coronary Angiography | 2 | 2020 | 2275 | 0.38 | Why? |
| Thromboxane B2 | 2 | 2017 | 23 | 0.36 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.32 | Why? |
| Heart Transplantation | 3 | 2020 | 1293 | 0.27 | Why? |
| Ventricular Fibrillation | 1 | 2020 | 126 | 0.19 | Why? |
| Social Control, Informal | 1 | 2018 | 20 | 0.19 | Why? |
| Aspirin | 2 | 2017 | 1043 | 0.19 | Why? |
| Sodium-Hydrogen Exchangers | 1 | 2018 | 22 | 0.19 | Why? |
| Central Venous Pressure | 1 | 2018 | 24 | 0.18 | Why? |
| Myocardial Revascularization | 1 | 2021 | 267 | 0.18 | Why? |
| Canagliflozin | 1 | 2018 | 56 | 0.18 | Why? |
| Health Status | 4 | 2018 | 3259 | 0.17 | Why? |
| Electric Countershock | 1 | 2020 | 284 | 0.17 | Why? |
| Dinoprost | 1 | 2017 | 49 | 0.17 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.16 | Why? |
| Kidney Diseases | 2 | 2018 | 1434 | 0.16 | Why? |
| Cardiac Surgical Procedures | 3 | 2019 | 1931 | 0.16 | Why? |
| Hypolipidemic Agents | 1 | 2018 | 208 | 0.16 | Why? |
| Oligonucleotides | 1 | 2017 | 137 | 0.15 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.15 | Why? |
| Prosthesis Design | 1 | 2018 | 594 | 0.15 | Why? |
| Benzhydryl Compounds | 1 | 2018 | 240 | 0.14 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.14 | Why? |
| Hyperlipoproteinemia Type II | 1 | 2017 | 123 | 0.14 | Why? |
| Anticholesteremic Agents | 1 | 2017 | 186 | 0.14 | Why? |
| Health Status Indicators | 1 | 2017 | 341 | 0.13 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.13 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.13 | Why? |
| Benzimidazoles | 1 | 2017 | 275 | 0.13 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.13 | Why? |
| Myocardial Ischemia | 1 | 2020 | 781 | 0.13 | Why? |
| Follow-Up Studies | 7 | 2021 | 17020 | 0.13 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.12 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.12 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.12 | Why? |
| Coronary Artery Disease | 2 | 2017 | 2570 | 0.12 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 451 | 0.11 | Why? |
| Dyslipidemias | 1 | 2018 | 791 | 0.11 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Waiting Lists | 1 | 2020 | 1388 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2018 | 667 | 0.11 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.11 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.10 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| Postoperative Complications | 2 | 2019 | 5861 | 0.10 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.10 | Why? |
| Treatment Outcome | 10 | 2020 | 51732 | 0.09 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.09 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.09 | Why? |
| Exercise | 2 | 2019 | 6771 | 0.09 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.09 | Why? |
| Aged | 14 | 2021 | 215776 | 0.09 | Why? |
| Texas | 3 | 2018 | 1237 | 0.09 | Why? |
| Sodium-Glucose Transporter 2 | 2 | 2018 | 111 | 0.09 | Why? |
| Female | 22 | 2021 | 380317 | 0.09 | Why? |
| Obesity, Morbid | 1 | 2019 | 1340 | 0.09 | Why? |
| Male | 20 | 2021 | 367725 | 0.08 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.08 | Why? |
| Missouri | 2 | 2018 | 274 | 0.08 | Why? |
| Biomarkers | 7 | 2018 | 23361 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Internationality | 1 | 2019 | 3297 | 0.08 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2021 | 5277 | 0.08 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Humans | 30 | 2021 | 930598 | 0.07 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2021 | 3361 | 0.07 | Why? |
| Leadership | 1 | 2018 | 2241 | 0.07 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.07 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.06 | Why? |
| Percutaneous Coronary Intervention | 1 | 2020 | 3646 | 0.06 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Nurses | 1 | 2018 | 2285 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Psychometrics | 2 | 2018 | 1269 | 0.05 | Why? |
| Aldosterone | 1 | 2021 | 155 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Survival Rate | 3 | 2020 | 9206 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.05 | Why? |
| Cause of Death | 3 | 2018 | 4823 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2017 | 46 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Anti-Arrhythmia Agents | 1 | 2020 | 325 | 0.04 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Isoantibodies | 1 | 2018 | 134 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Registries | 3 | 2020 | 12327 | 0.04 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2018 | 757 | 0.04 | Why? |
| Depression | 1 | 2019 | 14116 | 0.04 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.03 | Why? |
| United States | 2 | 2019 | 46150 | 0.03 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Adult | 9 | 2020 | 244371 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Italy | 3 | 2020 | 38444 | 0.03 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.03 | Why? |
| Heart Ventricles | 1 | 2019 | 1139 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Self Report | 1 | 2019 | 3802 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.02 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Health Behavior | 1 | 2019 | 4449 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
Tecson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_